DocuSign, Inc. Concurrent $443 Million Common Stock Offering and $575 Million Convertible Senior Notes Offering

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 8,060,550 shares of common stock of DocuSign, Inc. by certain...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

SpringWorks Therapeutics and BeiGene’s Global Clinical Collaboration

Goodwin advised SpringWorks Therapeutics on its global clinical collaboration with BeiGene to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene’s investigational RAF dimer inhibitor,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here